"This researcher went rogue," said Fernandez Lynch, the lawyer who specializes in medical ethics. "When one of their own goes rogue, a university should launch an aggressive investigation, interview the participants and make sure it never happens again."
The government officials contend that researchers did not officially seek permission for the trial, which took place from April to August 2016.
To ensure effective cost mitigation, employers can’t wait for the market to adjust — they have to punch first.
Neither the Food and Drug Administration nor a safety panel known as an institutional review board, or an “IRB,” monitored the testing of a vaccine its creators say prevents herpes outbreaks.